4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Absci Corporation (ABSI) operates in the Biotechnology industry and is headquartered in Vancouver, United States with about 140 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, ABSI reported $3M in revenue and ($115M) in net income.
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States.
Interactive charts & full statements → Open the ABSI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $3M | $4M | $6M | $6M | — |
| Operating Income (EBIT) | ($125M) | ($109M) | ($94M) | ($107M) | — |
| Net Income | ($115M) | ($103M) | ($111M) | ($105M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $1M | $1M | — |
| Operating Income (EBIT) | ($31M) | ($36M) | ($30M) | ($31M) | ($28M) | — |
| Net Income | ($30M) | ($30M) | ($29M) | ($31M) | ($26M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $216M | $214M | $217M | $321M | — |
| Total Liabilities | $27M | $34M | $41M | $47M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABSI viewer.
About TickerBase · Data methodology & sources